• No results found

University of Groningen Role of hepatic glucose signaling in the development of liver disease Lei, Yu

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Role of hepatic glucose signaling in the development of liver disease Lei, Yu"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Role of hepatic glucose signaling in the development of liver disease

Lei, Yu

DOI:

10.33612/diss.126530476

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Lei, Y. (2020). Role of hepatic glucose signaling in the development of liver disease. University of Groningen. https://doi.org/10.33612/diss.126530476

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Propositions

1. Hepatic ChREBP activation limits Non-Alcoholic Fatty Liver Disease development in murine Glycogen Storage Disease type Ia (GSD Ia). – This thesis

2. ChREBP promotes hepatic VLDL-triglyceride secretion in parallel to an induction of the expression of VLDL lipidation proteins MTTP and TM6SF2. – This thesis 3. Hepatic glucose-6-phosphate-ChREBP signaling regulates bile acid and

cholesterol metabolism via up-regulation of sterol 12 α-hydroylase (CYP8B1) activity in mice. – This thesis

4. ChREBP promotes hepatocyte proliferation in vitro but delays in vivo liver tumor development in GSD Ia mice. – This thesis

5. Attenuation of hepatic ChREBP induction in GSD Ia mice promotes DNA damage, chromosomal instability and hepatocyte death – This thesis

6. Hepatocyte G6pc deficiency in mice induces genomic instability and shifts the balance between hepatocyte hyperplasia and hypertrophy during liver regeneration. – This thesis

7. GLUT1 and GLUT2 show opposite expression patterns during human hepatocellular carcinoma (HCC) progression. – This thesis

8. Learning without thought is labor lost, thought without learning is perilous. – Confucius

Referenties

GERELATEERDE DOCUMENTEN

The role of the gaseous signaling molecule hydrogen sulfide in chronic liver disease: Special emphasis on non-alcoholic fatty liver disease.. University

As a result, pro-inflammatory signaling pathways are activated that promote the se- cretion of inflammatory cytokines (TNF-α, IL-6, IL-10) and the generation of reactive

ChREBP knockdown in immortalized human hepatocytes (IHHs) reduces cell proliferation while inducing p53 activity and cell cycle arrest. A, relative mRNA and protein levels

Notably, the increase in hepatocyte size in L-G6pc -/- mice was more pronounced as compared to wildtype controls (+ 25%) while liver mass recovery was comparable in both

We found that the expression of ChREBP showed a tendency to increase with liver malignancy, but unexpectedly, that GLUT2 protein expression was decreased in cancer cells compared

In human hepatoma Huh7 and HepG2 cells, TM6SF2 downregulation reduced the secretion of TG-rich lipoproteins and increased hepatic lipid droplet content, whereas TM6SF2

In this thesis, we employed a mouse model for hepatic GSD Ia (i.e., L-G6pc -/- mice) to study the physiological and molecular mechanisms that link intrahepatic glucose

an imbalance of hepatic G6P and TG as well as recurrent hypoglycemia in GSD I may affect hepatocyte proliferation and liver regeneration in response to PHx. The studies in this